查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
疫苗的全球市場:產業分析(2019年～2021年)-成長趨勢與市場預測(2022年～2029年)
市場調查報告書
商品編碼
1173648

疫苗的全球市場:產業分析(2019年～2021年)-成長趨勢與市場預測(2022年～2029年)

Vaccines Market - Global Industry Analysis (2019 - 2022), Growth Trends, and Market Forecast (2023 - 2029)
出版日期: | 出版商: Fairfield Market Research | 英文 160 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球疫苗的市場規模，預計從2021年到2029年的預測期間內的年複合成長率為11.2％(不包含COVID-19疫苗)，3.9％(包含COVID-19疫苗)。疫苗廠商和各國政府的投資活躍，促進市場成長。

本報告提供全球疫苗市場相關調查分析，市場概要，市場展望，競爭情形等系統性資訊。

目錄

第1章 摘要整理

  • 全球疫苗市場展望，金額(100萬美元)及數量(給藥數)(100萬次)(2019年～2029年)
  • 全球疫苗增加機會，金額(100萬美元)及數量(100萬次)(2019年～2029年)
  • 重要點

第2章 市場概要

  • 市場區隔和定義
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • COVID-19影響分析

第3章 疫苗供給的動態

  • 疫苗供給

第4章 疫苗的價格分析

  • 疫苗價格
  • 疫苗價格的變更

第5章 全球疫苗市場展望(2019年～2029年):各疫苗

  • 主要的焦點
  • 全球疫苗市場展望，金額(100萬美元)及數量(100萬次)(2019年～2029年):各疫苗
    • PCV
    • 含有D&T
    • HPV
    • 季節性流感
    • 帶狀皰疹
    • 輪狀病毒
    • 腦膜炎
    • MCV
    • 水痘
    • COVID-19
    • 其他
  • 全球疫苗市場佔有率與BPS(基點)分析(2023年及2029年):各疫苗
  • 全球疫苗市場魅力分析(2023年～2029年):各疫苗

第6章 全球疫苗市場展望(2019年～2029年):各國家群組

  • 主要的焦點
  • 全球疫苗市場展望，金額(100萬美元)及數量(100萬次)(2019年～2029年):各國家群組
    • PAHO RF(泛美國保健機構)
    • 自我採購HIC(高所得國)
    • 自我採購MIC(中所得國)
    • UNICEF(GAVI-疫苗和疫苗接種的世界聯盟)
    • UNICEF採購MIC(中所得國)
  • 全球疫苗市場佔有率與BPS(基點)分析(2023年及2029年):各國家群組
  • 全球疫苗市場魅力分析(2023年～2029年):各國家群組

第7章 全球疫苗市場展望(2019年～2029年):各地區

  • 主要的焦點
  • 全球疫苗市場展望，金額(100萬美元)及數量(100萬次)(2019年～2029年):各地區
    • 非洲(AFRO)
    • 南北美洲(AMRO)
    • 東地中海(EMRO)
    • 歐洲(EURO)
    • 南亞及東亞(SEARO)
    • 西太平洋(WPRO)
  • 全球疫苗市場佔有率與BPS(基點)分析(2023年及2029年):各地區
  • 全球疫苗市場魅力分析(2023年～2029年):各地區

第8章 全球疫苗市場展望(2019年～2029年):各企業

  • 主要的焦點
  • 全球疫苗市場展望，金額(100萬美元)及數量(100萬次)(2019年～2029年):各企業
    • AstraZeneca
    • GlaxoSmithKline plc.
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Moderna, Inc.
    • Novavax
    • Pfizer Inc.
    • Sanofi Pasteur
    • 其他
  • 全球疫苗市場佔有率與BPS(基點)分析(2023年及2029年):各企業

第9章 競爭情形

  • 企業的市場佔有率分析
  • 企業簡介
    • CSL Limited (Seqirus)
    • Emergent BioSolutions Inc.
    • GlaxoSmithKline plc.
    • Haffkine Bio-pharmaceutical Corporation Ltd.
    • Merck & Co., Inc.
    • Mitsubishi Tanabe Pharma Corporation
    • Moderna
    • Novavax
    • Pfizer Inc.
    • Sanofi Pasteur
    • Serum Institute of India Pvt. Ltd.
    • Sinopharm

第10章 附錄

  • 調查手法
  • 縮寫和簡稱
簡介目錄

Escalating investments by vaccine manufacturers, and governments from across the globe is predominantly driving the global vaccines market growth. This US$90 Bn market (2021) is projected to reach the valuation of US$82 Bn by the end of 2029. While vaccines market (excluding COVID-19 vaccine) is expected to demonstrate nearly 11.2% growth, the market (including COVID-19 vaccine) is likely to experience 3.9% growth through the end of forecast period. Epidemic, and pandemic situations like COVID-19 outbreak act as the key growth influencers for vaccines market, says a newly released market intelligence report of Fairfield Market Research.

Key Research Insights

  • Combination vaccines remain a significant growth contributor to vaccines space
  • Seasonal influenza vaccines slated for the fastest growth in demand by 2029 end
  • Shingles vaccine category represents a highly lucrative segment projected for nearly 15.5% growth in demand toward 2029
  • AMRO remains the top revenue contributor to vaccines market with nearly 50% share
  • Vaccine manufacturers gained steadfast profits during the COVID-19 outbreak, causing a titanic spike in market revenue. Post-2021, vaccines market (including COVID-19 vaccine) will observe the anticipated decline as the pandemic situation has been subsiding
  • A majority of market revenue remains concentrated within the top four - Pfizer, GSK, Sanofi, and Merck
  • Seasonal Flu Vaccines Continue to Lead Global Vaccines Market, Shingles Vaccine and PCV in Demand

Pneumococcal diseases continue to be one of the mortality causes worldwide among both children, and adults. There has thus been an increasing consideration about including Pneumococcal Conjugate Vaccine (PCV) in regular immunization programs. This is likely to be a continuous booster to the PCV segment in vaccines market. The WHO suggests over 150 nations across the globe to have introduced PCV in their routine immunization programs. While this keeps PCV consumption afloat in the market, the projections also suggest more than 40 nations to be in a process of implementation of the same. This according to the report will act as a significant driving force for spike in demand for PCV in global vaccines market. Demand will prominently thrive across populous nations like India, Indonesia, and China. In addition, the Human Papilloma Virus (HPV) vaccine is also expected to witness a sharp increase in demand, says the report. On the other hand, demand for seasonal influenza vaccines is projected to remain buoyant and will see the fastest growth through 2029. Shingles vaccine demand is however poised for a solid double-digit growth during the period of forecast.

SEARO, and WPRO All Set for Phenomenal Growth in Global Vaccines Market

Asia Pacific remains a significant market, led by the fast-developing nations like China, and India. While these nations have been the largest vaccine producers and the trend will prevail throughout the period of projection. The report identifies a continuous demand surge across the South and East Asia (SEARO), as well as the Western Pacific (WPRO) region. On the flipside, the report also states that the conventional high-value markets such as the US, and Canada in addition to the Americas (AMRO) are likely to be the top revenue contributors to global vaccines market. These markets are expected to capture around 50% of the overall vaccines market valuation over the next few years. The report marks AMRO as the most prominent vaccines market as the region is characterized by the relatively high value for Influenza (adult), Varicella, meningococcal vaccines, and HPV.

Global Vaccines Market - Key Competitors

Pfizer, GSK, Sanofi, and Merck represent the world leaders in vaccines space and collectively hold command over more than 90% of the overall manufacturing. The report also highlights 60% volume share of Sanofi, GSK, Bharat Biotech International Limited, Serum Institute of India, and Haffkine in worldwide vaccines production. Some of the prominent players that have been covered for detailed competitive profiling and strategic analysis, include Mitsubishi Tanabe Pharma Corporation, CSL Limited (Seqirus), Moderna, Emergent BioSolutions Inc., Novavax, and Sinopharm.

Table of Contents

1. Executive Summary

  • 1.1. Global Vaccines Market Outlook, Value (US$ Million) and Volume (Number of Doses) (Million), 2019 - 2029
  • 1.2. Global Vaccines Incremental Opportunity, Value (US$ Million) and Volume (Million), 2019 - 2029
  • 1.3. Key Takeaways

2. Market Overview

  • 2.1. Market Segmentations and Definitions
  • 2.2. Market Dynamics
    • 2.2.1. Market Drivers
    • 2.2.2. Market Restraints
    • 2.2.3. Market Opportunities
  • 2.3. COVID-19 Impact Analysis

3. Vaccines Supply Dynamics

  • 3.1. Vaccines Supply

4. Vaccines Pricing Analysis

  • 4.1. Vaccine Prices
  • 4.2. Vaccine Price Changes

5. Global Vaccines Market Outlook, By Vaccine, 2019-2029

  • 5.1. Key Highlights
  • 5.2. Global Vaccines Market Outlook, by Vaccine, Value (US$ Million) and Volume (Million), 2019 - 2029
    • 5.2.1. PCV
    • 5.2.2. D&T-containing
    • 5.2.3. HPV
    • 5.2.4. Seasonal Influenza
    • 5.2.5. Shingles
    • 5.2.6. Rotavirus
    • 5.2.7. Meningococcal
    • 5.2.8. MCVs
    • 5.2.9. Varicella
    • 5.2.10. COVID-19
    • 5.2.11. Others
  • 5.3. Global Vaccines Market Share and BPS (Basis Points) Analysis, by Vaccine, 2023 and 2029
  • 5.4. Global Vaccines Market Attractiveness Analysis, by Vaccine, 2023-2029

6. Global Vaccines Market Outlook, By Country Group , 2019-2029

  • 6.1. Key Highlights
  • 6.2. Global Vaccines Market Outlook, by Country Group, Value (US$ Million) and Volume (Million), 2019 - 2029
    • 6.2.1. PAHO RF (Pan American Health Organization)
    • 6.2.2. Self-procuring HICs (High Income Countries)
    • 6.2.3. Self-procuring MICs (Middle Income Countries)
    • 6.2.4. UNICEF (GAVI - Global Alliance for Vaccines and Immunizations)
    • 6.2.5. UNICEF-procuring MICs (Middle Income Countries)
  • 6.3. Global Vaccines Market Share and BPS (Basis Points) Analysis, by Country Group, 2023 and 2029
  • 6.4. Global Vaccines Market Attractiveness Analysis, by Country Group, 2023-2029

7. Global Vaccines Market Outlook, By Region, 2019-2029

  • 7.1. Key Highlights
  • 7.2. Global Vaccines Market Outlook, by Region, Value (US$ Million) and Volume (million), 2019 - 2029
    • 7.2.1. Africa (AFRO)
      • 7.2.1.1. Market Share Analysis, By Vaccine, Value (US$ Million)
      • 7.2.1.2. Market Share Analysis, By Dosage, value (US$ Million)
      • 7.2.1.3. Market Share Analysis, By Procurement Method, Value (US$ Million)
      • 7.2.1.4. Vaccines Supply and Pricing Analysis
      • 7.2.1.5. List of Manufacturers in the Region, By Vaccine
    • 7.2.2. Americas (AMRO)
      • 7.2.2.1. Market Share Analysis, By Value (US$ Million)
      • 7.2.2.2. Market Share Analysis, By Dosage (US$ Million)
      • 7.2.2.3. Market Share Analysis, By Procurement Method (US$ Million)
      • 7.2.2.4. Vaccines Supply and Pricing Analysis
      • 7.2.2.5. List of Manufacturers in the Region, By Vaccine
    • 7.2.3. Eastern Mediterranean (EMRO)
      • 7.2.3.1. Market Share Analysis, By Value (US$ Million)
      • 7.2.3.2. Market Share Analysis, By Dosage (US$ Million)
      • 7.2.3.3. Market Share Analysis, By Procurement Method (US$ Million)
      • 7.2.3.4. Vaccines Supply and Pricing Analysis
      • 7.2.3.5. List of Manufacturers in the Region, By Vaccine
    • 7.2.4. Europe (EURO)
      • 7.2.4.1. Market Share Analysis, By Value (US$ Million)
      • 7.2.4.2. Market Share Analysis, By Dosage (US$ Million)
      • 7.2.4.3. Market Share Analysis, By Procurement Method (US$ Million)
      • 7.2.4.4. Vaccines Supply and Pricing Analysis
      • 7.2.4.5. List of Manufacturers in the Region, By Vaccine
    • 7.2.5. South and East Asia (SEARO)
      • 7.2.5.1. Market Share Analysis, By Value (US$ Million)
      • 7.2.5.2. Market Share Analysis, By Dosage (US$ Million)
      • 7.2.5.3. Market Share Analysis, By Procurement Method (US$ Million)
      • 7.2.5.4. Vaccines Supply and Pricing Analysis
      • 7.2.5.5. List of Manufacturers in the Region, By Vaccine
    • 7.2.6. Western Pacific (WPRO)
      • 7.2.6.1. Market Share Analysis, By Value (US$ Million)
      • 7.2.6.2. Market Share Analysis, By Dosage (US$ Million)
      • 7.2.6.3. Market Share Analysis, By Procurement Method (US$ Million)
      • 7.2.6.4. Vaccines Supply and Pricing Analysis
      • 7.2.6.5. List of Manufacturers in the Region, By Vaccine
  • 7.3. Global Vaccines Market Share and BPS (Basis Points) Analysis, by Region, 2023 and 2029
  • 7.4. Global Vaccines Market Attractiveness Analysis, by Region, 2023-2029

8. Global Vaccines Market Outlook, By Company, 2019-2029

  • 8.1. Key Highlights
  • 8.2. Global Vaccines Market Outlook, by Company, Value (US$ Million), 2019 - 2029
    • 8.2.1. AstraZeneca
    • 8.2.2. GlaxoSmithKline plc.
    • 8.2.3. Johnson & Johnson
    • 8.2.4. Merck & Co., Inc.
    • 8.2.5. Moderna, Inc.
    • 8.2.6. Novavax
    • 8.2.7. Pfizer Inc.
    • 8.2.8. Sanofi Pasteur
    • 8.2.9. Others
  • 8.2. Global Vaccines Market Share and BPS (Basis Points) Analysis, by Company, 2023 and 2029

9. Competitive Landscape

  • 9.1. Company Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1. CSL Limited (Seqirus)
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product Portfolio
      • 9.2.1.4. Research and Development
      • 9.2.1.5. Recent Developments
    • 9.2.2. Emergent BioSolutions Inc.
    • 9.2.3. GlaxoSmithKline plc.
    • 9.2.4. Haffkine Bio-pharmaceutical Corporation Ltd.
    • 9.2.5. Merck & Co., Inc.
    • 9.2.6. Mitsubishi Tanabe Pharma Corporation
    • 9.2.7. Moderna
    • 9.2.8. Novavax
    • 9.2.9. Pfizer Inc.
    • 9.2.10. Sanofi Pasteur
    • 9.2.11. Serum Institute of India Pvt. Ltd.
    • 9.2.12. Sinopharm

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Acronyms and Abbreviations